GALD — Galderma AG Share Price
0.000.00%
Last trade - 00:00Consumer DefensivesSpeculative
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End null | Unit | null | null | null | null | null | nullE | nullE | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CH₣m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Galderma Group AG is a Switzerland based holding Company, specializing in dermatological treatments and skin care products. The Company, throw its subsidiaries, operates a portfolio of carious self-care brands focusing primarily on dermatological solutions, through its subsidiaries. production within the portfolio include neuromodulators, fillers. and biostimulators. these products are designed to relax winkles via injection, fill wrinkles in a specific location via injection and stimulate the body's cells to function optimally. The production process, for the various products primarily takes place in house, form research and development to manufacturing. In addition, including education, scientific engagements, and other services are offered.
Directors
- Last Annual
- Last Interim
- Incorporated
- February 7th, 2022
- Public Since
- March 22nd, 2024
- Sector
- Personal & Household Products & Services
- Industry
- Consumer Defensives
- Exchange
- SIX Swiss Exchange
- Address
- Zaehlerweg 10, ZUG, 6300
- Web
- https://www.galderma.com/
- Phone
- Auditors
Upcoming Events for GALD
Q3 2024 Galderma Group AG Trading Statement Release
FAQ
What is the Galderma AG share price?
As of Today at 19:08 UTC, shares in Galderma AG are trading at CH₣66.79. This share price information is delayed by 15 minutes.
How has the Galderma AG share price performed this year?
Shares in Galderma AG last closed at CH₣66.79 and the price had moved by over the past 365 days. In terms of relative price strength the Galderma AG share price has matched the FTSE Global All Cap Index by over the past year.
What are the analyst and broker recommendations for Galderma AG?
There is no consensus recommendation for this security.
What is the Galderma AG dividend yield?
Galderma AG does not currently pay a dividend.
Does Galderma AG pay a dividend?
Galderma AG does not currently pay a dividend.
When does Galderma AG next pay dividends?
Galderma AG does not currently pay a dividend.
How do I buy Galderma AG shares?
To buy shares in Galderma AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Galderma AG?
As of the previous close price of CH₣66.79, shares in Galderma AG had a market capitalisation of .
Where are Galderma AG shares listed?
Here are the trading details for Galderma AG:
- Country of listing: Switzerland
- Exchange: SWX
- Ticker Symbol: GALD
What kind of share is Galderma AG?
Based on an overall assessment of its quality, value and momentum Galderma AG is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Galderma AG share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Galderma AG share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Galderma AG. Over the past six months, its share price has matched the FTSE Global All Cap Index by .
As of the last closing price of CH₣66.79, shares in Galderma AG were trading +4.05% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Galderma AG PE Ratio?
The Galderma AG PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CH₣66.79.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Galderma AG?
We do not have data on Galderma AG's directors